Lenalidomide-C5-NH2
≥98%
- Product Code: 106247
CAS:
2093388-45-3
| Molecular Weight: | 329.39 g./mol | Molecular Formula: | C₁₈H₂₃N₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Lenalidomide-C5-NH2 is primarily utilized in the development of novel pharmaceutical compounds, particularly in the field of oncology. Its structure allows it to be a key intermediate in the synthesis of targeted cancer therapies, especially those designed to modulate the immune system and inhibit tumor growth. Researchers often employ it in the creation of proteolysis-targeting chimeras (PROTACs), which are innovative molecules that degrade specific proteins involved in cancer progression. Additionally, it is explored in the design of antibody-drug conjugates (ADCs), where it serves as a linker or payload to enhance the precision and efficacy of cancer treatments. Its application extends to experimental studies aimed at understanding and improving the therapeutic potential of immunomodulatory drugs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿24,300.00 |
+
-
|
| 0.500 | 10-20 days | ฿72,900.00 |
+
-
|
Lenalidomide-C5-NH2
Lenalidomide-C5-NH2 is primarily utilized in the development of novel pharmaceutical compounds, particularly in the field of oncology. Its structure allows it to be a key intermediate in the synthesis of targeted cancer therapies, especially those designed to modulate the immune system and inhibit tumor growth. Researchers often employ it in the creation of proteolysis-targeting chimeras (PROTACs), which are innovative molecules that degrade specific proteins involved in cancer progression. Additionally, it is explored in the design of antibody-drug conjugates (ADCs), where it serves as a linker or payload to enhance the precision and efficacy of cancer treatments. Its application extends to experimental studies aimed at understanding and improving the therapeutic potential of immunomodulatory drugs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :